창동신 (서울대학교)님 | 한빛사연구자 > 한빛사

서울대학교

CV File

약학

최종업데이트 2026.07.29.

Engineering the blood: Lipid nanoparticle platforms for ex vivo immune and hematopoietic cell therapies
- J. Control. Release, Available online 27 July 2026, 115211 | https://doi.org/10.1016/j.jconrel.2026.115211
- 2026-07
- 의약학
- 한빛사논문
Peroxiredoxin Ⅲ safeguards cardiac function against doxorubicin by regulating mitochondrial quality control via H2O2 detoxification
- Redox Biol., Available online 16 April 2026, 104176 | https://doi.org/10.1016/j.redox.2026.104176
- 2026-04
- 의약학
- 한빛사논문
Peroxiredoxin Ⅲ mitigates mitochondrial H2O2-mediated damage and supports quality control in cardiomyocytes under hypoxia-reoxygenation stress
- Redox Biol., Available online 5 August 2025, 103799 | https://doi.org/10.1016/j.redox.2025.103799
- 2025-08
- 의약학
- 한빛사논문
Targeting NADPH Oxidase with APX-115: Suppression of Platelet Activation and Thrombotic Response
- Antioxid. Redox Signal., Apr 04 2025, | https://doi.org/10.1089/ars.2024.0695
- 2025-04
- 의약학
- 한빛사논문
p57KIP2 Modulates Stress-activated Signaling by Inhibiting c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase
- J. Biol. Chem., 278, 48092-48098. November 28, 2003 | doi: 10.1074/jbc.M309421200
- 2003-11
- 생명과학
- 구.추천논문
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
- J. Biol. Chem., 279, 41975-41984(October 1, 2004) doi: 10.1074/jbc.M407707200
- 2004-10
- 상위피인용논문
Characterization of Mammalian Sulfiredoxin and Its Reactivation of Hyperoxidized Peroxiredoxin through Reduction of Cysteine Sulfinic Acid in the Active Site to Cysteine*
- J. Biol. Chem., 279, 50994-51001(December 3, 2004). doi: 10.1074/jbc.M409482200
- 2004-12
- 상위피인용논문
Regulation of Peroxiredoxin I Activity by Cdc2-mediated Phosphorylation
- J. Biol. Chem., 277, 25370-25376. First Published on May 1, 2002, doi: 10.1074/jbc.M110432200
- 2002-05
- 상위피인용논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기